Search results for " STEM CELLS"

showing 10 items of 881 documents

Menstruation: science and society

2020

© 2020 The Authors Women's health concerns are generally underrepresented in basic and translational research, but reproductive health in particular has been hampered by a lack of understanding of basic uterine and menstrual physiology. Menstrual health is an integral part of overall health because between menarche and menopause, most women menstruate. Yet for tens of millions of women around the world, menstruation regularly and often catastrophically disrupts their physical, mental, and social well-being. Enhancing our understanding of the underlying phenomena involved in menstruation, abnormal uterine bleeding, and other menstruation-related disorders will move us closer to the goal of p…

GerontologyBiomedical ResearchEndometriosisHealth literacyTranslational researchContext (language use)Global HealthEducationMenstruation03 medical and health sciencesEndometrium0302 clinical medicineTerminology as TopicMedicineHumansRegeneration030212 general & internal medicineMenstrual Hygiene ProductsDeveloping CountriesMenstruation DisturbancesReproductive health030219 obstetrics & reproductive medicineLeiomyomaTissue Engineeringbusiness.industryMicrobiotaStem CellsUterusTranslational medicineObstetrics and GynecologyNational Institute of Child Health and Human Development (U.S.)Mesenchymal Stem CellsCongresses as TopicMicrofluidic Analytical Techniquesmedicine.diseaseBiological EvolutionUnited StatesHealth LiteracyMenstruationMenopauseAttitudeUterine NeoplasmsMenarcheWomen's HealthFemaleUterine HemorrhagebusinessAdenomyosis
researchProduct

Exposure to N-ethyl-N-nitrosourea in adult mice alters structural and functional integrity of neurogenic sites.

2011

BackgroundPrevious studies have shown that prenatal exposure to the mutagen N-ethyl-N-nitrosourea (ENU), a N-nitroso compound (NOC) found in the environment, disrupts developmental neurogenesis and alters memory formation. Previously, we showed that postnatal ENU treatment induced lasting deficits in proliferation of neural progenitors in the subventricular zone (SVZ), the main neurogenic region in the adult mouse brain. The present study is aimed to examine, in mice exposed to ENU, both the structural features of adult neurogenic sites, incorporating the dentate gyrus (DG), and the behavioral performance in tasks sensitive to manipulations of adult neurogenesis.Methodology/principal findin…

GerontologyMaleHippocampusHippocampuschemistry.chemical_compoundMiceMolecular Cell BiologyStem Cell NicheNeuronsMultidisciplinaryStem CellsNeurogenesisQAge FactorsRCell DifferentiationEnvironmental exposureAnimal ModelsAdult Stem Cellsmedicine.anatomical_structureMedicineCellular TypesBromodeoxyuridineAdult stem cellResearch Articlemedicine.medical_specialtyAlkylating AgentsNeurogenesisScienceImmunologySubventricular zoneBiologyModel OrganismsDevelopmental NeuroscienceInternal medicinemedicineotorhinolaryngologic diseasesAnimalsBiologyMemory DisordersDentate gyrusEnvironmental ExposureBarnes mazeEndocrinologychemistryEthylnitrosoureaDentate GyrusImmunologic TechniquesClinical ImmunologyDevelopmental BiologyNeurosciencePLoS ONE
researchProduct

Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adul…

2010

Mesenchymal stem cells (MSC) are uniquely capable of crossing germinative layers borders (i.e. are able to differentiate towards ectoderm-, mesoderm- and endoderm-derived cytotypes) and are viewed as promising cells for regenerative medicine approaches in several diseases. Type I diabetes therapy should potentially benefit from such differentiated cells: the search for alternatives to organ/islet transplantation strategies via stem cells differentiation is an ongoing task, significant goals having been achieved in most experimental settings (e.g. insulin production and euglycaemia restoration), though caution is still needed to ensure safe and durable effects in vivo. MSC are obtainable in …

Graft RejectionCancer ResearchCellular differentiationCell Culture TechniquesClinical uses of mesenchymal stem cellsBiologyMesenchymal Stem Cell TransplantationRegenerative medicineUmbilical CordImmunomodulationMesenchymal stem cells Umbilical cord Wharton’s jelly Type 1 diabetes Beta cells Differentiation markers Pancreas development Inflammation Immune modulation HypoimmunogenicityInsulin-Secreting CellsWharton's jellyAnimalsHumansRegenerationEmbryonic Stem CellsSettore BIO/16 - Anatomia UmanaRegeneration (biology)Mesenchymal stem cellCell DifferentiationMesenchymal Stem CellsCell BiologyAntigens DifferentiationTransplantationAdult Stem CellsDiabetes Mellitus Type 1Adipose TissueImmunologyCancer researchCord Blood Stem Cell TransplantationStem cellStem Cell Reviews and Reports
researchProduct

Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium?

2006

Objectives: To assess the functional effects of multipotent adult progenitor cells (MAPCs) transplanted in a rat model of chronic myocardial infarction. Methods: Forty-four rats underwent coronary ligation and, 14 days later, were randomly allocated to receive in-scar injections (5×106 cells/150 μL) of green fluorescent protein (eGFP)-transduced allogeneic MAPCs ( n =25) or culture medium (controls, n =19). Nine of the MAPC-treated hearts were employed for functional studies while the remaining 16 received cells co-labeled with Resovist™ and were only used for serial histological assessments. Left ventricular (LV) function was assessed echocardiographically before transplantation and 1 mont…

Graft RejectionPathologymedicine.medical_specialtyEndotheliumPhysiologyMyocardial InfarctionBone Marrow CellsRats Sprague-DawleyPhysiology (medical)MedicineAnimalsMyocardial infarctionTreatment FailureProgenitor cellbusiness.industryMultipotent Stem CellsMyocardiummedicine.diseaseMyocardial ContractionRatsTransplantationmedicine.anatomical_structureMultipotent Stem CellModels AnimalImmunohistochemistryFemaleBone marrowStem cellCardiology and Cardiovascular MedicinebusinessCardiovascular research
researchProduct

Precision medicine in breast cancer: reality or utopia?

2017

International audience; Many cancers, including breast cancer, have demonstrated prognosis and support advantages thanks to the discovery of targeted therapies. The advent of these new approaches marked the rise of precision medicine, which leads to improve the diagnosis, prognosis and treatment of cancer. Precision medicine takes into account the molecular and biological specificities of the patient and their tumors that will influence the treatment determined by physicians. This new era of medicine is accessible through molecular genetics platforms, the development of high-speed sequencers and means of analysis of these data. Despite the spectacular results in the treatment of cancers inc…

HER2+0301 basic medicineTumor heterogeneitymedicine.medical_specialtyPathologyMolecular subtypeslcsh:MedicineBreast NeoplasmsReviewCancer VaccinesTumor heterogeneityGeneral Biochemistry Genetics and Molecular BiologyGenetic Heterogeneity03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancer[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyHumansChemotherapyMedicineMedical physicsTriple negativebusiness.industrylcsh:RPrecision medicineCancerGeneral MedicinePrecision medicinemedicine.disease3. Good health030104 developmental biology030220 oncology & carcinogenesisNeoplastic Stem CellsTriple-negativeFemaleImmunotherapyPhase III clinical trialsbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyJournal of Translational Medicine
researchProduct

Selective MicroRNA-Offset RNA Expression in Human Embryonic Stem Cells

2015

Small RNA molecules, including microRNAs (miRNAs), play critical roles in regulating pluri-potency, proliferation and differentiation of embryonic stem cells. miRNA-offset RNAs (moRNAs) are similar in length to miRNAs, align to miRNA precursor (pre-miRNA) loci and are therefore believed to derive from processing of the pre-miRNA hairpin sequence. Recent next generation sequencing (NGS) studies have reported the presence of moRNAs in human neurons and cancer cells and in several tissues in mouse, including pluripotent stem cells. In order to gain additional knowledge about human moRNAs and their putative development-related expression, we applied NGS of small RNAs in human embryonic stem cel…

HUMAN DICERSmall RNAHuman Embryonic Stem CellsMolecular Sequence Datalcsh:MedicineGene ExpressionBiologyPLURIPOTENCYCell LinemicroRNAGene expressionmiRNA-offset RNAsELEMENTSHumansSmall nucleolar RNAlcsh:ScienceInduced pluripotent stem cellGene LibraryGENE-EXPRESSIONGeneticsBinding SitesMultidisciplinaryBase Sequenceta1184Gene Expression ProfilingMATURE MICRORNASMORNASlcsh:RComputational BiologyHigh-Throughput Nucleotide SequencingRNAMolecular Sequence AnnotationRNA sequencingembryonic stem cellsEmbryonic stem cellmicroRNAsCell biologyMicroRNAsMIRNASDISCOVERYMOUSE ES CELLSRNA Small Untranslatedlcsh:Q3111 BiomedicineRNA extractionFEEDER CELLSSequence AlignmentResearch ArticlePLOS ONE
researchProduct

Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation

2015

In the last decade there has been a rapid expansion in clinical trials using mesenchymal stromal cells (MSCs) from a variety of tissues. However, despite similarities in morphology, immunophenotype, and differentiation behavior in vitro, MSCs sourced from distinct tissues do not necessarily have equivalent biological properties. We performed a genome-wide methylation, transcription, and in vivo evaluation of MSCs from human bone marrow (BM), white adipose tissue, umbilical cord, and skin cultured in humanized media. Surprisingly, only BM-derived MSCs spontaneously formed a BM cavity through a vascularized cartilage intermediate in vivo that was progressively replaced by hematopoietic tissue…

Hematopoiesis and Stem CellsCellular differentiationBlotting WesternImmunologyCD34Bone Marrow CellsBiologyBiochemistryEpigenesis GeneticOsteogenesismedicineHumansCell LineageStem Cell NichefungiMesenchymal stem cellHematopoietic Tissuefood and beveragesCell DifferentiationMesenchymal Stem CellsCell BiologyHematologyAnatomyFlow CytometryHematopoietic Stem CellsCell biologyTransplantationmedicine.anatomical_structureBone marrowStem cellChondrogenesisHoming (hematopoietic)Blood
researchProduct

EFFECTIVENESS OF G-CSF+PLERIXAFOR MOBILIZATION IN β- THALASSEMIA PATIENTS AND WHOLE GENE EXPRESSION ANALYSIS OF THE HARVESTED CD34+ CELLS

2014

Hematopoietic Stem Cells Mobilization Microarray
researchProduct

Intra-individual Gene Expression Profiling of Peripheral Blood CD34+ Hematopoietic Stem Cells Mobilized by Two Different Protocols

2014

Hematopoietic Stem Cells Gene Expression Profiling Mobilization.
researchProduct

Direct Toll-Like Receptor-Mediated Stimulation of Hematopoietic Stem and Progenitor Cells Occurs In Vivo and Promotes Differentiation Toward Macropha…

2012

Abstract As Toll-like receptors (TLRs) are expressed by hematopoietic stem and progenitor cells (HSPCs), they may play a role in hematopoiesis in response to pathogens during infection. We show here that TLR2, TLR4, and TLR9 agonists (tripalmitoyl-S-glyceryl-L-Cys-Ser-(Lys)4 [Pam3CSK4], lipopolysaccharide [LPS], and CpG oligodeoxynucleotide [ODN]) induce the in vitro differentiation of purified murine lineage negative cells (Lin−) as well as HSPCs (identified as Lin− c-Kit+ Sca-1+ IL-7Rα− [LKS] cells) toward macrophages (Mph), through a myeloid differentiation factor 88 (MyD88)-dependent pathway. In order to investigate the possible direct interaction of soluble microorganism-associated mol…

Hematopoietic stem and progenitor cellsBiologyCell LineMicemedicineAnimalsProgenitor cellToll-like receptorInnate immune systemMacrophagesToll-Like ReceptorsTLR9Cell DifferentiationCell BiologyFlow CytometryHematopoietic Stem CellsMyD88Molecular biologyToll-Like Receptor 2Toll-like receptorsMice Inbred C57BLToll-Like Receptor 4TLR2Haematopoiesismedicine.anatomical_structureMyeloid Differentiation Factor 88TLR4Molecular MedicineBone marrowDevelopmental BiologySignal Transduction
researchProduct